<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Anesth Essays Res</journal-id><journal-id journal-id-type="iso-abbrev">Anesth Essays Res</journal-id><journal-id journal-id-type="publisher-id">AER</journal-id><journal-title-group><journal-title>Anesthesia, Essays and Researches</journal-title></journal-title-group><issn pub-type="ppub">0259-1162</issn><issn pub-type="epub">2229-7685</issn><publisher><publisher-name>Medknow Publications &#x00026; Media Pvt Ltd</publisher-name><publisher-loc>India</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">25885721</article-id><article-id pub-id-type="pmc">4173499</article-id><article-id pub-id-type="publisher-id">AER-7-54</article-id><article-id pub-id-type="doi">10.4103/0259-1162.113992</article-id><article-categories><subj-group subj-group-type="heading"><subject>Original Article</subject></subj-group></article-categories><title-group><article-title>Effect of tramadol on perioperative immune function in patients undergoing gastric cancer surgeries</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Zhou</surname><given-names>Li-Wen</given-names></name><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name><surname>Ding</surname><given-names>Han-Lin</given-names></name><xref ref-type="aff" rid="aff1"/><xref ref-type="corresp" rid="cor1"/></contrib><contrib contrib-type="author"><name><surname>Li</surname><given-names>Ming-Qiang</given-names></name><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name><surname>Jin</surname><given-names>Sheng</given-names></name><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name><surname>Wang</surname><given-names>Xue-Song</given-names></name><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name><surname>Ji</surname><given-names>Li-Juan</given-names></name><xref ref-type="aff" rid="aff1"/></contrib></contrib-group><aff id="aff1">Department of Anesthesiology, Xiangyang Central Hospital, Hubei University of Arts and Science, Hubei Province, China</aff><author-notes><corresp id="cor1">
Corresponding author: Dr. Han-Lin Ding, Department of Anesthesiology, Xiangyang Central Hospital, Hubei University of Arts and Science, Xiangyang &#x02013; 441 000, China. E-mail: <email xlink:href="zlwxf@tom.com">zlwxf@tom.com</email></corresp></author-notes><pub-date pub-type="ppub"><season>Jan-Apr</season><year>2013</year></pub-date><volume>7</volume><issue>1</issue><fpage>54</fpage><lpage>57</lpage><permissions><copyright-statement>Copyright: &#x000a9; Anesthesia: Essays and Researches</copyright-statement><copyright-year>2013</copyright-year><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc-sa/3.0"><license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><abstract><sec id="st1"><title>Background:</title><p>A prospective randomized controlled trial was designed to observe the effect of tramadol on T-lymphocyte subsets, activated T cell and natural killer (NK) cells of patients undergoing gastric cancer surgeries.</p></sec><sec id="st2"><title>Subjects and Methods:</title><p>Thirty patients undergoing elective gastric cancer surgeries under general anesthesia were randomly divided into two groups. Before anesthesia induction, Group I did not receive any drugs and Group II received intramuscular tramadol 1 mg/kg. Peripheral venous blood samples were taken before anesthesia, 1 h after incision and postoperation. CD3<sup>+</sup>, CD3<sup>+</sup> CD4<sup>+</sup>, CD3<sup>+</sup> CD8<sup>+</sup>, CD3<sup>&#x02013;</sup>CD16<sup>+</sup> CD56<sup>+</sup> (NK) cells and CD3<sup>+</sup> human leukocyte antigen (HLA)-DR<sup>+</sup> (activated T cell) were measured by flow cytometer.</p></sec><sec id="st3"><title>Results:</title><p>One hour after incision, CD3<sup>+</sup>, CD3<sup>+</sup> CD4+, CD3<sup>+</sup> CD4<sup>+</sup>/CD3<sup>+</sup> CD8<sup>+</sup>, CD3<sup>-</sup>CD16<sup>+</sup> CD56<sup>+</sup>, and CD3<sup>+</sup> HLA-DR<sup>+</sup> cells in the experimental and control group were significantly decreased compared with their baselines (<italic>P</italic> &#x0003c; 0.05), while the values of Group I were lower than those of Group II (<italic>P</italic> &#x0003c; 0.05). After surgery, the values of Group I were lower than their baselines (<italic>P</italic> &#x0003c; 0.05). But the values of Group II had no significant difference compared with their baselines.</p></sec><sec id="st4"><title>Conclusion:</title><p>Tramadol can reduce the decrease of T-lymphocytes subsets and NK cells, thus improve the cellular immune function in the perioperation of gastric cancer.</p></sec></abstract><kwd-group><kwd>Gastric cancer</kwd><kwd>killer cells</kwd><kwd>natural</kwd><kwd>tramadol</kwd><kwd>T-lymphocyte subsets</kwd></kwd-group></article-meta></front><body><sec sec-type="intro" id="sec1-1"><title>INTRODUCTION</title><p>Many studies both in the animal and in the human have revealed that surgery is associated with a relevant immunosuppression. Injuries and stressed caused by surgeries are the primary reasons of immunity depression.[<xref rid="ref1" ref-type="bibr">1</xref><xref rid="ref2" ref-type="bibr">2</xref>] However, the immune effect of anesthesia and pain relief should also be considered.[<xref rid="ref3" ref-type="bibr">3</xref><xref rid="ref4" ref-type="bibr">4</xref>] Many analgesics, for example, morphine used for the treatment of intraoperative pain decreased the quantity and activity of lymphoproliferation and natural killer (NK) cell. But analgesic drug tramadol could prevent the immunosuppression effect of surgery in rats.[<xref rid="ref5" ref-type="bibr">5</xref>] Furthermore, it is not clear about the immune effect of tramadol in the cancer patients during the perioperation. A trial was designed to observe the expressions of peripheral blood T-lymphocyte subsets (CD3<sup>+</sup>, CD3<sup>+</sup> CD4<sup>+</sup> and CD3<sup>+</sup> CD8<sup>+</sup>), NK cells (CD3<sup>&#x02212;</sup> CD16<sup>+</sup> CD56<sup>+</sup>) and activated T cell (CD3<sup>+</sup> HLA-DR<sup>+</sup>) in patients scheduled for gastric cancer through given tramadol before anesthesia.</p></sec><sec sec-type="methods" id="sec1-2"><title>SUBJECTS AND METHODS</title><sec id="sec2-1"><title>Approval and consent obtained</title><p>The study was approved by the ethics committee of the Xiangyang Central Hospital and conducted according to the principles of the Helsinki Declaration. An informed, written consent was obtained from each of the clinical patients included in the study.</p></sec><sec id="sec2-2"><title>Patients&#x02019; selection</title><p>Thirty patients (age: 20-69) with American Society of Anesthesiologists (ASA) physical status I or II scheduled for gastric cancer surgeries under general anesthesia were enrolled in this trial. All the patients did not receive radiotherapy, chemotherapy, immunodepressants, or blood transfusion before the surgery. Patients who received intraoperative therapies of corticosteroids or blood transfusion were also excluded.</p></sec><sec id="sec2-3"><title>Anesthesia methods</title><p>Phenobarbital sodium 0.1 g and atropine 0.5 g were intramuscular injected 30 min before anesthesia. All the patients were randomly divided into Groups I and II. Before anesthesia induction, Group I did not receive any drugs and Group II received intramuscular tramadol 1 mg/kg. Midazolam 0.1 mg/kg, propofol 1-1.5 mg/kg, atracurium 0.6-1 mg/kg, and remifentanil 1-2 <italic>&#x003bc;</italic>g/kg induced anesthesia. Anesthesia was maintained with continuous infusion of remifentanil 0.2-0.3 ug/kg/min, propofol 0.05-0.07 mg/kg/min, and atracurium 8-10 ug/kg/min. Mean arterial blood pressure fluctuated between the 10% of the preoperation. All the patients did not receive patient control intravenous analgesia.</p></sec><sec id="sec2-4"><title>Study methods</title><p>Peripheral venous blood samples were taken before anesthesia, 1 h after incision and postoperation. CD3<sup>+</sup>, CD3<sup>+</sup> CD4<sup>+</sup>, CD3<sup>+</sup> CD8<sup>+</sup>, NK cells, and HLA-DR were measured by flow cytometer.</p></sec><sec id="sec2-5"><title>Statistical analyses</title><p>All the data were expressed as Mean &#x000b1; SD (standard deviation). Statistical analyses were conducted using SPSS 16.0. Results were analyzed by one-way analysis of variance. Statistical significance was set at <italic>P</italic> &#x0003c; 0.05.</p></sec></sec><sec sec-type="results" id="sec1-3"><title>RESULTS</title><p>There was no significant difference between Group I and Group II with regard to age, weight, gender, ASA physical status, and surgery duration [<xref ref-type="table" rid="T1">Table 1</xref>].</p><table-wrap id="T1" position="float"><label>Table 1</label><caption><p>Demographic data and surgery duration</p></caption><graphic xlink:href="AER-7-54-g001"/></table-wrap><p>CD3<sup>+</sup>, CD4<sup>+</sup>, CD3<sup>+</sup> CD8<sup>+</sup> and CD3<sup>+</sup> CD4<sup>+</sup>/CD3<sup>+</sup> CD8<sup>+</sup></p><p>There was no significant difference between the baselines of CD3<sup>+</sup>, CD3<sup>+</sup> CD4<sup>+</sup> and CD3<sup>+</sup> CD4<sup>+</sup>/CD3<sup>+</sup> CD8<sup>+</sup> of two groups [<xref ref-type="table" rid="T2">Table 2</xref>]. One hour after incision, CD3<sup>+</sup>, CD3<sup>+</sup> CD4<sup>+</sup> and CD3<sup>+</sup> CD4<sup>+</sup>/CD3<sup>+</sup> CD8<sup>+</sup> of two groups decreased compared with their baselines (<italic>P</italic> &#x0003c; 0.05), while those of Group I was lower than those of Group II (<italic>P</italic> &#x0003c; 0.05). After surgery, CD3<sup>+</sup>, CD3<sup>+</sup> CD4<sup>+</sup> and CD3<sup>+</sup> CD4<sup>+</sup>/CD3<sup>+</sup> CD8<sup>+</sup> of Group I was lower than their baselines, but CD3<sup>+</sup>, CD3<sup>+</sup> CD4<sup>+</sup> and CD3<sup>+</sup> CD4<sup>+</sup>/CD3<sup>+</sup> CD8<sup>+</sup> of Group II had no significant difference compared with their baselines. CD3<sup>+</sup> CD8<sup>+</sup> of two groups at different time points had no significant difference. In the <xref ref-type="fig" rid="F1">Figure 1</xref>, the values of CD3<sup>+</sup>, CD3<sup>+</sup> CD4<sup>+</sup>, CD3<sup>+</sup> CD8<sup>+</sup> were in the upright.</p><table-wrap id="T2" position="float"><label>Table 2</label><caption><p>The value of CD3<sup>+</sup>, CD3<sup>+</sup>CD4<sup>+</sup>, CD3<sup>+</sup>CD8<sup>+</sup>, CD4<sup>+</sup>/CD8<sup>+</sup>, CD3<sup>-</sup>CD16<sup>+</sup>CD56<sup>+</sup>, and CD3<sup>+</sup>HLA&#x02013;DR<sup>+</sup> in the two groups</p></caption><graphic xlink:href="AER-7-54-g002"/></table-wrap><fig id="F1" position="float"><label>Figure 1</label><caption><p>The scatterplots of CD3<sup>+</sup>, CD3<sup>+</sup>CD4<sup>+</sup>, CD3<sup>+</sup>CD8<sup>+</sup> in the two groups. The values of CD3<sup>+</sup>, CD3<sup>+</sup>CD4<sup>+</sup>, and CD3<sup>+</sup>CD8<sup>+</sup> were in the upright</p></caption><graphic xlink:href="AER-7-54-g003"/></fig><p>CD3<sup>-</sup>CD16<sup>+</sup> CD56<sup>+</sup> (NK cells)</p><p>There was no significant difference between the baselines of two groups. One hour after incision, NK cells of Group I and Group II decreased compared with their lines (<italic>P</italic> &#x0003c; 0.05). After surgery, NK cell of Group I was lower than the baselines (<italic>P</italic> &#x0003c; 0.05), but NK cell of Group II returned to the baselines. In the <xref ref-type="fig" rid="F2">Figure 2</xref>, the values of CD3<sup>-</sup>CD16<sup>+</sup> CD56<sup>+</sup> were in the upleft.</p><fig id="F2" position="float"><label>Figure 2</label><caption><p>The scatterplots of CD3<sup>&#x02013;</sup>CD16<sup>+</sup>CD56<sup>+</sup> in the two groups. The values of CD3<sup>&#x02013;</sup>CD16<sup>+</sup>CD56<sup>+</sup> were in the upleft</p></caption><graphic xlink:href="AER-7-54-g004"/></fig><p>CD3<sup>+</sup> HLA-DR<sup>+</sup></p><p>There was no significant difference between the baselines of two groups. One hour after incision, CD3<sup>+</sup> HLA-DR<sup>+</sup> of Group I and Group II were lower than their baseline (<italic>P</italic> &#x0003c; 0.05). After surgery, CD3<sup>+</sup> HLA-DR<sup>+</sup> of Group I was still lower than the baseline (<italic>P</italic> &#x0003c; 0.05), while CD3<sup>+</sup> HLA-DR<sup>+</sup> of Group II returned to the baseline. In the <xref ref-type="fig" rid="F3">Figure 3</xref>, the values of CD3<sup>+</sup> HLA-DR<sup>+</sup> were in the upright.</p><fig id="F3" position="float"><label>Figure 3</label><caption><p>The scatterplots of CD3<sup>+</sup>HLA-DR<sup>+</sup> in the two groups. The values of CD3<sup>+</sup>HLA-DR<sup>+</sup> were in the upright</p></caption><graphic xlink:href="AER-7-54-g005"/></fig></sec><sec sec-type="discussion" id="sec1-4"><title>DISCUSSION</title><p>Gastric cancer patients commonly undergo surgical procedures, and the perioperative period is characterized by immunosuppression and may predispose already immunosupressed cancer patients to tumor spread.[<xref rid="ref6" ref-type="bibr">6</xref>] Possible mediating factors for immunosuppression during the operation include anesthetic agents,[<xref rid="ref7" ref-type="bibr">7</xref>] blood transfusions,[<xref rid="ref8" ref-type="bibr">8</xref>] pain,[<xref rid="ref4" ref-type="bibr">4</xref>] and surgical stress.[<xref rid="ref9" ref-type="bibr">9</xref>]</p><p>T-lymphocytes and NK cells are the important immune active cells in the peripheral blood circulation, whose expressions of surface antigen and some receptors are vital for the immune system. It caused tumor spread in the gastric cancer patients that the surgery decreased T cells and NK cells during the operation. HLA-DR molecules are expressed on the surface of professional antigen-presenting cells such as macrophages, dendritic cells, and B-cells and on activated T-lymphocytes, activated NK cells and human progenitor cells. CD3<sup>+</sup> HLA-DR<sup>+</sup> cells are the activated T-lymphocytes. As they are required for antigen presentation and activation of T-lymphocytes, they play a central role in the specific immune response to infection.[<xref rid="ref10" ref-type="bibr">10</xref><xref rid="ref11" ref-type="bibr">11</xref><xref rid="ref12" ref-type="bibr">12</xref>] In our study, CD3<sup>+</sup>, CD3<sup>+</sup> CD4<sup>+</sup>, CD3<sup>+</sup> CD4<sup>+</sup>/CD3<sup>&#x02212;</sup> CD8<sup>&#x02212;</sup>, CD3<sup>&#x02212;</sup> CD16<sup>+</sup> CD56<sup>+</sup>, and CD3<sup>+</sup> HLA-DR<sup>+</sup> cells were lower than their lines of two groups 1 h after incision, which showed that the surgery decreased T-cells and NK cells in all the patients and so caused perioperative immunosuppression.</p><p>Many authors reported that tramadol could increase NK cell and T-lymphocyte proliferation <italic>in vivo</italic> and <italic>in vitro</italic>. Gaspani, <italic>et al</italic>.,[<xref rid="ref5" ref-type="bibr">5</xref>] have revealed that the analgesic drug tramadol prevents the effect of surgery on NK cell activity and metastatic colonization in rats. Wang, <italic>et al</italic>.,[<xref rid="ref13" ref-type="bibr">13</xref>] showed that the administration of tramadol improved immune functions during postoperation in gastric cancer patients. So Group II, we given the anesthetic drug tramadol before the anesthesia. One hour after incision, the T cells, activated T cells, and NK cells of Group II were lower than their baseline. After surgery, the immune function returned to the baseline in the Group II, but the immune function was lower than the baseline in the Group I. The results showed that the administration of tramadol improved the immunosuppression due to surgery and returned to the baselines more quickly.</p></sec><sec sec-type="conclusion" id="sec1-5"><title>CONCLUSION</title><p>Our data suggest that the anesthetic drug tramadol can reduce the decrease of T-lymphocytes subsets and NK cells, thus improve the cellular immune function in the perioperation of gastric cancer. The improvement of immune function of gastrointestinal cancer patients with postoperative infection and tumor metastasis remains to be further research.</p></sec></body><back><fn-group><fn fn-type="supported-by"><p><bold>Source of Support:</bold> Nil</p></fn><fn fn-type="conflict"><p><bold>Conflict of Interest:</bold> None declared.</p></fn></fn-group><ref-list><title>REFERENCES</title><ref id="ref1"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shimaoka</surname><given-names>M</given-names></name><name><surname>Hosotsubo</surname><given-names>K</given-names></name><name><surname>Sugimoto</surname><given-names>M</given-names></name><name><surname>Sakaue</surname><given-names>G</given-names></name><name><surname>Taenaka</surname><given-names>N</given-names></name><name><surname>Yoshiya</surname><given-names>I</given-names></name><etal/></person-group><article-title>The influence of surgical stress on T cells: Enhancement of early phase lymphocyteactivation</article-title><source>Anesth Analg</source><year>1998</year><volume>87</volume><fpage>1431</fpage><lpage>35</lpage><pub-id pub-id-type="pmid">9842843</pub-id></element-citation></ref><ref id="ref2"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ogawa</surname><given-names>K</given-names></name><name><surname>Hirai</surname><given-names>M</given-names></name><name><surname>Katsube</surname><given-names>T</given-names></name><name><surname>Murayama</surname><given-names>M</given-names></name><name><surname>Hamaguchi</surname><given-names>K</given-names></name><name><surname>Shimakawa</surname><given-names>T</given-names></name><etal/></person-group><article-title>Suppression of cellular immunity by surgical stress</article-title><source>Surgery</source><year>2000</year><volume>127</volume><fpage>329</fpage><lpage>36</lpage><pub-id pub-id-type="pmid">10715990</pub-id></element-citation></ref><ref id="ref3"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kehlet</surname><given-names>H</given-names></name><name><surname>Dahl</surname><given-names>JB</given-names></name></person-group><article-title>Anaesthesia, surgery, and challenges in postoperative recovery</article-title><source>Lancet</source><year>2003</year><volume>362</volume><fpage>1921</fpage><lpage>28</lpage><pub-id pub-id-type="pmid">14667752</pub-id></element-citation></ref><ref id="ref4"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Page</surname><given-names>GG</given-names></name></person-group><article-title>Surgery-induced immunosuppression and postoperative pain management</article-title><source>AACN Clin Issues</source><year>2005</year><volume>16</volume><fpage>302</fpage><lpage>9</lpage><pub-id pub-id-type="pmid">16082233</pub-id></element-citation></ref><ref id="ref5"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gaspani</surname><given-names>L</given-names></name><name><surname>Bianchi</surname><given-names>M</given-names></name><name><surname>Limiroli</surname><given-names>E</given-names></name><name><surname>Panerai</surname><given-names>AE</given-names></name><name><surname>Sacerdote</surname><given-names>P</given-names></name></person-group><article-title>The analgesic drug tramadol prevents the effect of surgery on natural killer cell activity and metastatic colonization in rats</article-title><source>J Neuroimmunol</source><year>2002</year><volume>129</volume><fpage>18</fpage><lpage>24</lpage><pub-id pub-id-type="pmid">12161016</pub-id></element-citation></ref><ref id="ref6"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Milasiene</surname><given-names>V</given-names></name><name><surname>Stratilatovas</surname><given-names>E</given-names></name><name><surname>Norkiene</surname><given-names>V</given-names></name></person-group><article-title>The importance of T-lymphocyte subsets on overall survival of colorectal and gastric cancer patients</article-title><source>Medicina (Kaunas)</source><year>2007</year><volume>43</volume><fpage>548</fpage><lpage>54</lpage><pub-id pub-id-type="pmid">17768369</pub-id></element-citation></ref><ref id="ref7"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Melamed</surname><given-names>R</given-names></name><name><surname>Bar-Yosef</surname><given-names>S</given-names></name><name><surname>Shakhar</surname><given-names>G</given-names></name><name><surname>Shakhar</surname><given-names>K</given-names></name><name><surname>Ben-Eliyahu</surname><given-names>S</given-names></name></person-group><article-title>Suppression of natural killer cell activity and promotion of tumor metastasis by ketamine, thiopental, and halothane, but not by propofol mediating mechanisms and prophylactic measures</article-title><source>Anesth Analg</source><year>2003</year><volume>97</volume><fpage>1331</fpage><lpage>9</lpage><pub-id pub-id-type="pmid">14570648</pub-id></element-citation></ref><ref id="ref8"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vallejo</surname><given-names>R</given-names></name><name><surname>Hord</surname><given-names>ED</given-names></name><name><surname>Barna</surname><given-names>SA</given-names></name><name><surname>Santiago-Palma</surname><given-names>J</given-names></name><name><surname>Ahmed</surname><given-names>S</given-names></name></person-group><article-title>Perioperative immunosuppression in cancer patients</article-title><source>J Environ Pathol Toxicol Oncol</source><year>2003</year><volume>22</volume><fpage>139</fpage><lpage>46</lpage><pub-id pub-id-type="pmid">14533877</pub-id></element-citation></ref><ref id="ref9"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Edwards</surname><given-names>JA</given-names></name><name><surname>Durant</surname><given-names>BM</given-names></name><name><surname>Jones</surname><given-names>DB</given-names></name><name><surname>Evans</surname><given-names>PR</given-names></name><name><surname>Smith</surname><given-names>JL</given-names></name></person-group><article-title>Differential expression of HLA class II antigens in fetal human spleen: Relationship of HLA-DP, DQ, and DR to immunoglobulin expression</article-title><source>J Immunol</source><year>1986</year><volume>137</volume><fpage>490</fpage><lpage>7</lpage><pub-id pub-id-type="pmid">3522732</pub-id></element-citation></ref><ref id="ref10"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Levacher</surname><given-names>M</given-names></name><name><surname>Tallet</surname><given-names>S</given-names></name><name><surname>Dazza</surname><given-names>MC</given-names></name><name><surname>Dournon</surname><given-names>E</given-names></name><name><surname>Rouveix</surname><given-names>B</given-names></name><name><surname>Pocidalo</surname><given-names>JJ</given-names></name></person-group><article-title>T activation marker evaluation in ARC patients treated with AZT. Comparison with CD4+lymphocyte count in non-progressors and progressors towards AIDS</article-title><source>Clin Exp Immunol</source><year>1990</year><volume>81</volume><fpage>177</fpage><lpage>82</lpage><pub-id pub-id-type="pmid">1696859</pub-id></element-citation></ref><ref id="ref11"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Terstappen</surname><given-names>LW</given-names></name><name><surname>Hollander</surname><given-names>Z</given-names></name><name><surname>Meiners</surname><given-names>H</given-names></name><name><surname>Loken</surname><given-names>MR</given-names></name></person-group><article-title>Quantitative comparison of myeloid antigens on five lineages of mature peripheral blood cells</article-title><source>J Leukoc Biol</source><year>1990</year><volume>48</volume><fpage>138</fpage><lpage>48</lpage><pub-id pub-id-type="pmid">2196321</pub-id></element-citation></ref><ref id="ref12"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cheadle</surname><given-names>WG</given-names></name></person-group><article-title>The human leukocyte antigens and their relationship to infection</article-title><source>Am J Surg</source><year>1993</year><volume>165</volume><fpage>75S</fpage><lpage>81S</lpage><pub-id pub-id-type="pmid">8439003</pub-id></element-citation></ref><ref id="ref13"><label>13</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>ZY</given-names></name><name><surname>Wang</surname><given-names>CQ</given-names></name><name><surname>Yang</surname><given-names>JJ</given-names></name><name><surname>Sun</surname><given-names>J</given-names></name><name><surname>Huang</surname><given-names>YH</given-names></name><name><surname>Tang</surname><given-names>QF</given-names></name><etal/></person-group><article-title>Which has the least immunity depression during postoperative analgesia-Morphine, tramadol, or tramadol with lornoxicam?</article-title><source>Clin Chim Acta</source><year>2006</year><volume>369</volume><fpage>40</fpage><lpage>5</lpage><pub-id pub-id-type="pmid">16487501</pub-id></element-citation></ref></ref-list></back></article>